Second Supplemental Security Agreement

Recorded: 2005-01-25 Received: 2005-01-28 Pages: 12

Assignors

ANDA, INC.

Executed: 2004-04-01

ANDRX LABS, LLC

Executed: 2004-04-01

ANDRX PHARMACEUTICALS, LLC

Executed: 2004-04-01

Assignee

BANK OF AMERICA, N.A.

600 PEACHTREE STREET, N.E., ATLANTA, GA, 30303, UNITED STATES

Covered Properties (10)

Jet Impingement Cooling Apparatus and Method

Application: 11/037,677 →

Novel Pharmaceutical Formulation Containing a Biguanide and a Thiazolidinedione Derivative

Application: 10/777,542 →

Dosage Form Holder Device and Methods for Immersion Testing

Application: 10/768,277 →

Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug

Application: 60/537,862 →

Extended Release Venlafaxine Formulation

Application: 10/715,219 →

Omeprazole Formulation

Application: 10/712,505 →

Decongestant and expectorant system

Application: 60/516,983 →

Itraconazole immediate release formulation

Application: 10/679,760 →

Novel Pharmaceutical Formulation Containing a Biguanide and a Thiazolidinedione Derivative

Application: 10/664,803 →

System and method for pharmacy restocking applications

Application: 10/637,816 →